Michael Schmidt Score: 34
Analyst at
Guggenheim
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+40.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
71%
17 W / 7 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
55%
6 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
9%
1 W / 10 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 11 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
76%
16 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
74%
17 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 06, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$240.00
Est. +22%
|
$197.30 | $208.76 |
Pending
|
$202.00
+2.4%
|
| Aug 06, 2026 |
UroGen Pharma Ltd
URGN
|
BUY |
$58.00
Est. +25%
|
$46.43 | $49.67 |
Pending
|
$48.13
+3.7%
|
| Aug 06, 2026 |
Enliven Therapeutics Inc
ELVN
|
BUY |
$78.00
Est. +31%
|
$59.70 | $61.77 |
Pending
|
$58.06
-2.7%
|
| Jul 09, 2026 |
Revolution Medicines Inc
RVMD
|
BUY |
$235.00
Est. +24%
|
$189.77 | $208.76 |
Pending
|
$202.00
+6.4%
|
| Feb 23, 2026 |
Genmab - ADR
GMAB
|
BUY |
$40.00
Est. +37%
|
$29.29 | $31.79 |
Pending
|
$31.34
+7.0%
|
| Jan 20, 2026 |
CytomX Therapeutics Inc
CTMX
|
BUY |
$10.00
Est. +86%
|
$5.39 | $8.20 |
Pending
|
$3.35
-37.8%
|
| Nov 12, 2025 |
Adc Therapeutics SA
ADCT
|
BUY |
$10.00
Est. +152%
|
$3.97 | $4.97 |
Pending
|
$1.05
-73.6%
|
| Oct 24, 2025 |
Tango Therapeutics Inc
TNGX
|
BUY |
$12.00
Est. +53%
|
$7.85 | $33.53 |
Target Met
|
$25.65
+226.8%
|
| Sep 23, 2025 |
Genmab - ADR
GMAB
|
BUY |
$43.00
Est. +50%
|
$28.60 | $35.43 |
Pending
|
$31.34
+9.6%
|
| Jun 03, 2025 |
Blueprint Medicines Corp
BPMC
|
BUY |
$132.00
Est. +3%
|
$127.60 | $129.65 |
Precision Hit (±3%)
|
$129.46
+1.5%
|
| Jun 03, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$60.00
Est. +38%
|
$43.58 | $103.00 |
Target Met
|
$114.42
+162.6%
|
| May 15, 2025 |
Exelixis Inc
EXEL
|
SELL |
$45.00
Est. +3%
|
$46.26 | $33.76 (Low) |
Target Met
|
$50.61
-9.4%
|
| May 14, 2025 |
Erasca Inc
ERAS
|
BUY |
$3.00
Est. +136%
|
$1.27 | $24.28 |
Target Met
|
$17.86
+1306.3%
|
| Mar 24, 2025 |
Verastem Inc
VSTM
|
BUY |
$14.00
Est. +103%
|
$6.88 | $11.25 |
Miss
|
$6.67
-3.1%
|
| Jan 08, 2025 |
SpringWorks Therapeutics Inc
SWTX
|
BUY |
$78.00
Est. +89%
|
$41.20 | $61.57 |
Miss
|
$46.99
+14.1%
|
| Jan 07, 2025 |
Exelixis Inc
EXEL
|
BUY |
$42.00
Est. +23%
|
$34.21 | $49.40 |
Target Met
|
$50.61
+47.9%
|
| Oct 28, 2024 |
Revolution Medicines Inc
RVMD
|
BUY |
$82.00
Est. +75%
|
$46.96 | $62.40 |
Miss
|
$202.00
+330.2%
|
| Aug 27, 2024 |
Nanobiotix - ADR
NBTX
|
BUY |
$12.00
Est. +134%
|
$5.13 | $10.59 |
Miss
|
$38.17
+644.1%
|
| Apr 15, 2024 |
Immunome Inc
IMNM
|
BUY |
$35.00
Est. +70%
|
$20.58 | $16.81 |
Miss
|
$26.42
+28.4%
|
| Oct 13, 2022 |
BeiGene Ltd - ADR
BGNE
|
BUY |
$205.00
Est. +35%
|
$151.30 | - | - |
$184.71
+22.1%
|
| Jan 03, 2022 |
Incyte Corp.
INCY
|
BUY |
$104.00
Est. +41%
|
$73.97 | - | - |
$120.52
+62.9%
|
| Jan 03, 2022 |
Blueprint Medicines Corp
BPMC
|
BUY |
$122.00
Est. +11%
|
$110.08 | - | - |
$129.46
+17.6%
|
| Jan 03, 2022 |
Allogene Therapeutics Inc
ALLO
|
BUY |
$35.00
Est. +129%
|
$15.29 | - | - |
$1.98
-87.1%
|
| Jun 28, 2021 |
Exelixis Inc
EXEL
|
BUY |
$30.00
Est. +66%
|
$18.02 | - | - |
$50.61
+180.9%
|
Revolution Medicines Inc
RVMD
Aug 06, 2026
Signal & Target
BUY
$240.00
Start Price
$197.30
Best Price (1Y)
$208.76
Current Price
$202.00
Return
+2.4%
UroGen Pharma Ltd
URGN
Aug 06, 2026
Signal & Target
BUY
$58.00
Start Price
$46.43
Best Price (1Y)
$49.67
Current Price
$48.13
Return
+3.7%
Enliven Therapeutics Inc
ELVN
Aug 06, 2026
Signal & Target
BUY
$78.00
Start Price
$59.70
Best Price (1Y)
$61.77
Current Price
$58.06
Return
-2.7%
Revolution Medicines Inc
RVMD
Jul 09, 2026
Signal & Target
BUY
$235.00
Start Price
$189.77
Best Price (1Y)
$208.76
Current Price
$202.00
Return
+6.4%
Genmab - ADR
GMAB
Feb 23, 2026
Signal & Target
BUY
$40.00
Start Price
$29.29
Best Price (1Y)
$31.79
Current Price
$31.34
Return
+7.0%
CytomX Therapeutics Inc
CTMX
Jan 20, 2026
Signal & Target
BUY
$10.00
Start Price
$5.39
Best Price (1Y)
$8.20
Current Price
$3.35
Return
-37.8%
Adc Therapeutics SA
ADCT
Nov 12, 2025
Signal & Target
BUY
$10.00
Start Price
$3.97
Best Price (1Y)
$4.97
Current Price
$1.05
Return
-73.6%
Tango Therapeutics Inc
TNGX
Oct 24, 2025
Signal & Target
BUY
$12.00
Start Price
$7.85
Best Price (1Y)
$33.53
Current Price
$25.65
Return
+226.8%
Genmab - ADR
GMAB
Sep 23, 2025
Signal & Target
BUY
$43.00
Start Price
$28.60
Best Price (1Y)
$35.43
Current Price
$31.34
Return
+9.6%
Blueprint Medicines Corp
BPMC
Jun 03, 2025
Signal & Target
BUY
$132.00
Start Price
$127.60
Best Price (1Y)
$129.65
Current Price
$129.46
Return
+1.5%
Kymera Therapeutics Inc
KYMR
Jun 03, 2025
Signal & Target
BUY
$60.00
Start Price
$43.58
Best Price (1Y)
$103.00
Current Price
$114.42
Return
+162.6%
Exelixis Inc
EXEL
May 15, 2025
Signal & Target
SELL
$45.00
Start Price
$46.26
Best Price (1Y)
$33.76
Current Price
$50.61
Return
-9.4%
Erasca Inc
ERAS
May 14, 2025
Signal & Target
BUY
$3.00
Start Price
$1.27
Best Price (1Y)
$24.28
Current Price
$17.86
Return
+1306.3%
Verastem Inc
VSTM
Mar 24, 2025
Signal & Target
BUY
$14.00
Start Price
$6.88
Best Price (1Y)
$11.25
Current Price
$6.67
Return
-3.1%
SpringWorks Therapeutics Inc
SWTX
Jan 08, 2025
Signal & Target
BUY
$78.00
Start Price
$41.20
Best Price (1Y)
$61.57
Current Price
$46.99
Return
+14.1%
Exelixis Inc
EXEL
Jan 07, 2025
Signal & Target
BUY
$42.00
Start Price
$34.21
Best Price (1Y)
$49.40
Current Price
$50.61
Return
+47.9%
Revolution Medicines Inc
RVMD
Oct 28, 2024
Signal & Target
BUY
$82.00
Start Price
$46.96
Best Price (1Y)
$62.40
Current Price
$202.00
Return
+330.2%
Nanobiotix - ADR
NBTX
Aug 27, 2024
Signal & Target
BUY
$12.00
Start Price
$5.13
Best Price (1Y)
$10.59
Current Price
$38.17
Return
+644.1%
Immunome Inc
IMNM
Apr 15, 2024
Signal & Target
BUY
$35.00
Start Price
$20.58
Best Price (1Y)
$16.81
Current Price
$26.42
Return
+28.4%
BeiGene Ltd - ADR
BGNE
Oct 13, 2022
Signal & Target
BUY
$205.00
Start Price
$151.30
Best Price (1Y)
-
Current Price
$184.71
Return
+22.1%
Incyte Corp.
INCY
Jan 03, 2022
Signal & Target
BUY
$104.00
Start Price
$73.97
Best Price (1Y)
-
Current Price
$120.52
Return
+62.9%
Blueprint Medicines Corp
BPMC
Jan 03, 2022
Signal & Target
BUY
$122.00
Start Price
$110.08
Best Price (1Y)
-
Current Price
$129.46
Return
+17.6%
Allogene Therapeutics Inc
ALLO
Jan 03, 2022
Signal & Target
BUY
$35.00
Start Price
$15.29
Best Price (1Y)
-
Current Price
$1.98
Return
-87.1%
Exelixis Inc
EXEL
Jun 28, 2021
Signal & Target
BUY
$30.00
Start Price
$18.02
Best Price (1Y)
-
Current Price
$50.61
Return
+180.9%